Company Filing History:
3 out of 785 
1 out of 8,684 
1 out of 15,475 
Years Active: 2000-2019
Title: Innovations and Contributions of Stephen M Boyle
Introduction
Stephen M Boyle is a notable inventor based in Blacksburg, VA (US), recognized for his significant contributions to the field of vaccine development. With a total of 5 patents, his work focuses on creating innovative solutions for infectious diseases.
Latest Patents
One of his latest patents is a multivalent vaccine for protection against mycobacterial infections. This vaccine expresses at least one heterologous antigen and serves as an environmentally safe bivalent vaccine for simultaneous protection against infections. Specifically, it comprises a strain transformed with a vector that expresses at least one antigen, which is codon optimized for the strain. In some aspects, the strain is RB51 leuB, and the antigens include Ag85B, Rv2660c, and ESAT6. Another significant patent involves the development of a live, attenuated, recombinant vaccine for Brucellosis. This vaccine utilizes a recombinant, attenuated strain with a deficiency in carboxyl-terminal protease activity or tail-specific protease activity, aimed at preventing or treating Brucellosis.
Career Highlights
Stephen has worked with Virginia Tech Intellectual Properties, Inc. and the U.S. Government as represented by the Secretary of the Army. His career reflects a commitment to advancing public health through innovative vaccine research.
Collaborations
Throughout his career, Stephen has collaborated with notable individuals such as Gerhardt G Schurig and Nammalwar Sriranganathan, contributing to the advancement of vaccine technology.
Conclusion
Stephen M Boyle's innovative work in vaccine development has made a significant impact on the field of infectious disease prevention. His contributions continue to pave the way for future advancements in public health.